H&M (Hennes & Mauritz) vs Johnson & Johnson
Side-by-side comparison of AI visibility scores, market position, and capabilities
Global fast-fashion giant with 4,100+ stores across 78 markets. Q1 2026 revenue up 3%; investing in AI personalization and sustainability initiatives.
About
H&M (Hennes & Mauritz) is a Swedish multinational fast-fashion retailer founded in 1947 by Erling Persson in Västerås, Sweden. Originally a women's clothing store named "Hennes" (Swedish for "Hers"), the company acquired hunting equipment and clothing brand Mauritz Widforss in 1968 and rebranded. Today H&M operates as one of the world's largest fashion retailers, with a core mission of delivering trend-forward clothing at accessible prices across a broad demographic.\n\nH&M's business spans 4,100+ stores across 78 markets along with a significant e-commerce presence. The company operates multiple brands under the H&M Group umbrella, including COS, ARKET, Weekday, & Other Stories, and Monki. H&M is investing heavily in AI-driven personalization tools to improve the online shopping experience and optimize inventory management. The value proposition centers on fast turnover of affordable, on-trend styles for men, women, and children.\n\nH&M generates approximately $23 billion in annual revenue. Q1 2026 revenue grew 3% year-over-year as the group continued its recovery from post-pandemic inventory challenges. The company faces ongoing pressure from ultra-fast fashion competitors like Shein and Temu, and is responding with sustainability commitments, AI personalization, and a tighter focus on its premium sub-brands to maintain differentiation and margin.
FY2024 Sales: $88.8B (+4.3%) | Net Profit: $14.1B (+5.6%) | EPS: $5.79 | Adjusted EPS: $9.98 | FY2025 Guidance: Operational Sales Growth 2.5-3.5%, Adj EPS $10.75-$10.95 (+8.7% midpoint)
About
Johnson & Johnson is one of the world's largest healthcare companies, founded in 1886 by brothers Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson in New Brunswick, New Jersey, where the company remains headquartered. Established to manufacture ready-to-use surgical dressings at a time when post-operative infection was a leading cause of surgical mortality, J&J was built on the scientific principles of antiseptic surgery advocated by Joseph Lister. The company trades on the NYSE under ticker JNJ and has evolved over 135+ years from a consumer health products manufacturer into a focused MedTech and pharmaceutical enterprise, completing the spinoff of its consumer health segment (Kenvue) in 2023.\n\nJohnson & Johnson now operates through two segments: Innovative Medicine and MedTech. Innovative Medicine encompasses oncology, immunology, neuroscience, infectious disease, and cardiovascular pharmaceutical products — including blockbusters Darzalex, Stelara, Tremfya, and Rybrevant. The MedTech segment includes surgical robotics (Ottava platform in development), electrophysiology (Abiomed, Biosense Webster), orthopedics (DePuy Synthes), and surgery systems, serving hospitals and surgical centers worldwide. Following the Kenvue separation, J&J is a pure-play healthcare technology and pharmaceutical company with significantly higher growth and margin profiles than its historical blended consumer-pharma-medtech structure.\n\nJohnson & Johnson reported FY2024 sales of $88.8 billion, up 4.3% year over year, with net profit of $14.1 billion, up 5.6%. The company's Innovative Medicine segment continues to grow driven by oncology and immunology portfolio strength, while MedTech benefits from procedure volume recovery and robotic surgery adoption. J&J's scale, R&D pipeline depth, and global commercial infrastructure — spanning more than 60 countries — position it as one of the two or three most consequential healthcare enterprises globally, with a patent portfolio, clinical trial network, and regulatory expertise that are nearly impossible to replicate.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
H&M (Hennes & Mauritz) vs
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.